Literature DB >> 18203965

Polycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference?

George U Liepa1, Aditi Sengupta, Danielle Karsies.   

Abstract

Polycystic ovary syndrome (PCOS) is a condition that involves the excess production of androgens. It affects up to 10% of all American women and can lead to the development of acne, hirsutism, and infertility. It has also been associated with coronary heart disease, diabetes, and metabolic syndrome. Over half of the women who are diagnosed with PCOS are overweight or obese. Recommendations are made for overweight/obese women to lose weight via diet and exercise. Women with PCOS should also consider maintaining a diet that is patterned after the type 2 diabetes diet. This diet includes an increase in fiber and a decrease in refined carbohydrates, as well as a decrease in trans and saturated fats and an increase in omega-3 and omega-9 fatty acids. Foods that contain anti-inflammatory compounds (fiber, omega-3 fatty acids, vitamin E, and red wine) should also be emphasized. Evidence is provided for the impact of these dietary changes on improvements in the androgen profile of PCOS patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203965     DOI: 10.1177/011542650802300163

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  12 in total

1.  Dietary Carbohydrate Intake Does Not Impact Insulin Resistance or Androgens in Healthy, Eumenorrheic Women.

Authors:  Lindsey A Sjaarda; Enrique F Schisterman; Karen C Schliep; Torie Plowden; Shvetha M Zarek; Edwina Yeung; Jean Wactawski-Wende; Sunni L Mumford
Journal:  J Clin Endocrinol Metab       Date:  2015-06-12       Impact factor: 5.958

2.  [In Process Citation]

Authors:  Jonette E Keri; Adena E Rosenblatt
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

Review 3.  Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.

Authors:  Dimitrios Panidis; Konstantinos Tziomalos; Efstathios Papadakis; Christos Vosnakis; Panagiotis Chatzis; Ilias Katsikis
Journal:  Endocrine       Date:  2013-04-27       Impact factor: 3.633

4.  PLASMA NEPRILYSIN LEVELS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME.

Authors:  O Oz Gul; P Sisman; S Cander; E Sarandol; C Ersoy; E Erturk
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

5.  Aloe barbadensis Mill. formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model.

Authors:  Bhavna N Desai; Radha H Maharjan; Laxmipriya P Nampoothiri
Journal:  Pharmacognosy Res       Date:  2012-04

Review 6.  The Deep Correlation between Energy Metabolism and Reproduction: A View on the Effects of Nutrition for Women Fertility.

Authors:  Roberta Fontana; Sara Della Torre
Journal:  Nutrients       Date:  2016-02-11       Impact factor: 5.717

7.  Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity.

Authors:  A Couto Alves; B Valcarcel; V-P Mäkinen; L Morin-Papunen; S Sebert; A J Kangas; P Soininen; S Das; M De Iorio; L Coin; M Ala-Korpela; M-R Järvelin; S Franks
Journal:  Int J Obes (Lond)       Date:  2017-05-26       Impact factor: 5.095

Review 8.  N-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications.

Authors:  Mina Salek; Cain C T Clark; Mohsen Taghizadeh; Sadegh Jafarnejad
Journal:  EXCLI J       Date:  2019-07-25       Impact factor: 4.068

9.  An update on plant derived anti-androgens.

Authors:  Paul Grant; Shamin Ramasamy
Journal:  Int J Endocrinol Metab       Date:  2012-04-20

10.  Tetragonia tetragonioides (Pall.) Kuntze Regulates Androgen Production in a Letrozole-Induced Polycystic Ovary Syndrome Model.

Authors:  Bo-Jeong Pyun; Hyun Yang; Eunjin Sohn; Song Yi Yu; Dongoh Lee; Dong Ho Jung; Byoung Seob Ko; Hye Won Lee
Journal:  Molecules       Date:  2018-05-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.